This article is more than 5 years old. Information may no longer be current.
6 Highly Read Articles from ACR 2015 Highlight Rheumatoid Arthritis
Readers of Healio Rheumatology showed interest in the research about rheumatoid arthritis presented at the American College of Rheumatology Annual Meeting in November in San Francisco.
Based on the number of page views, the new guidelines for treating rheumatoid arthritis (RA) published by the American College of Rheumatology (ACR) garnered the most attention and shares. More of Healio Rheumatology’s live coverage, including video interviews with researchers, can be found by clicking here.
ACR releases 2015 guidelines for the treatment of RA
The ACR announced the release of the 2015 treatment guidelines for patients with RA during a press conference at the group’s annual meeting. Read more.
Methotrexate may be underused in US by patients with RA
Methotrexate may be prescribed to patients with RA at low doses, for an inadequate length of time and rarely in subcutaneous form prior to the initiation of a biologic therapy, according to research presented by James O’Dell, MD. Read more.
VIDEO: Rituximab retreatment associated with greater sustained response
Leslie R. Harrold, MD, MPH, an associate professor at the University of Massachusetts Medical School and a Corrona researcher, spoke about the factors associated with sustained response in patients with RA who received rituximab within the U.S. Corrona Registry. Read more.
Second anti-TNF or other biologic may help some RA patients who failed initial anti-TNF treatment
Research presented showed almost half of patients with RA who did not respond to treatment with a first anti-tumor necrosis factor biologic responded to a second treatment with a different biologic — regardless of anti-drug antibody status — although a biologic drug of a different mechanism of action may be more effective. Read more.
Certain biomarkers may differentiate chikungunya from RA
The presence of cyclic citrullinated peptide antibodies and 14-3-3eta in sera may help to distinguish RA from infection with the chikungunya virus, according to recently presented research. Read more.
Care for depression, sleep may relieve fatigue in patients with RA, axSpA
Advance care for depression, sleep and functional deficits may relieve persistent fatigue in patients with either RA or axial spondyloarthritis (axSpA) and low disease activity, according to researchers in Saint-Étienne, France. Read more.